BIOXCEL THERAPEUTICS INC
BTAI·09075P105·UQ·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
BTAI (BIOXCEL THERAPEUTICS INC) is held by 32 institutional investors as of Q2 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($3M), OAKTREE CAPITAL MANAGEMENT LP ($1.9M), VANGUARD CAPITAL MANAGEMENT LLC ($1.3M). Net institutional sentiment: Bullish.
32
Holders
(3 Elite)
$8.2M
Total Value
76% (21)
Consensus
16 buying - 5 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 8, 2026 · Insiders Jun 17, 2026 · Activists Mar 30, 2026 · Congress none
InsiderRJRodriguez JavierExercise 35 shJun 15, 2026
InsiderYFYocca FrankExercise 35 shJun 15, 2026
InsiderMVMehta VimalExercise 219 shJun 15, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 33
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer